Terns Pharmaceuticals (TERN) Earnings Date & Reports

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TERN is expected to report earnings to rise 24.71% to -29 cents per share on May 19

Terns Pharmaceuticals TERN Stock Earnings Reports

Q1'25

Est.

$-0.30

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.05

The last earnings report on March 20 showed earnings per share of -23 cents, beating the estimate of -30 cents. With 891.66K shares outstanding, the current market capitalization sits at 209.51M.

View a ticker or compare two or three

Compare

TERN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TERN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1065 East Hillsdale Boulevard

Phone

+1 650 525-5535

Employees

Web

https://www.ternspharma.com